Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Nakano

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Asia Pacific Journal of Clinical Nutrition|July 22, 2016
Contribution of hypoalbuminemia and decreased renal function to the increased mortality after newly diagnosed vertebral fracture in Japanese subjectsTetsuo Nakano, Akiko Kuwabara, Hiroshi Mizuta, et al.
Journal of Orthopaedic Trauma|September 16, 2011
Predictors for ambulatory ability and the change in ADL after hip fracture in patients with different levels of mobility before injury: a 1-year prospective cohort studyNaoshi Fukui, Yoshinobu Watanabe, Tetsuo Nakano, et al.
Bioscience, Biotechnology, and Biochemistry|August 7, 2018
Novel methods for nucleotide length control in double-stranded polyinosinic-polycytidylic acid production using uneven length componentsTetsuo Nakano, Ei-Tora Yamamura, Hiroshi Fujita, et al.
Calcified Tissue International|November 15, 2011
The risk of a second hip fracture in patients after their first hip fractureHiroshi Hagino, Takeshi Sawaguchi, Naoto Endo, et al.
Journal of Bone and Mineral Metabolism|October 15, 2015
Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER studyTetsuo Nakano, Masao Yamamoto, Junko Hashimoto, et al.
Asia Pacific Journal of Clinical Nutrition|March 12, 2011
High prevalence of hypovitaminosis D and K in patients with hip fractureTetsuo Nakano, Naoko Tsugawa, Akiko Kuwabara, et al.
Bioscience, Biotechnology, and Biochemistry|June 25, 2004
Identification and cloning of the gene involved in the final step of chlortetracycline biosynthesis in Streptomyces aureofaciensTetsuo Nakano, Koichiro Miyake, Hirofumi Endo, et al.
Brain Research|February 24, 2009
Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized miceFeng Han, Tetsuo Nakano, Yui Yamamoto, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|May 20, 2011
Serum 25-hydroxyvitamin D status in hip and spine-fracture patients in JapanMayumi Sakuma, Naoto Endo, Hiroshi Hagino, et al.
Calcified Tissue International|May 7, 2013
Clinical efficacy on fracture risk and safety of 0.5 mg or 1 mg/month intravenous ibandronate versus 2.5 mg/day oral risedronate in patients with primary osteoporosisToshitaka Nakamura, Tetsuo Nakano, Masako Ito, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Asia Pacific Journal of Clinical Nutrition|July 22, 2016
Contribution of hypoalbuminemia and decreased renal function to the increased mortality after newly diagnosed vertebral fracture in Japanese subjectsTetsuo Nakano, Akiko Kuwabara, Hiroshi Mizuta, et al.
Journal of Orthopaedic Trauma|September 16, 2011
Predictors for ambulatory ability and the change in ADL after hip fracture in patients with different levels of mobility before injury: a 1-year prospective cohort studyNaoshi Fukui, Yoshinobu Watanabe, Tetsuo Nakano, et al.
Bioscience, Biotechnology, and Biochemistry|August 7, 2018
Novel methods for nucleotide length control in double-stranded polyinosinic-polycytidylic acid production using uneven length componentsTetsuo Nakano, Ei-Tora Yamamura, Hiroshi Fujita, et al.
Calcified Tissue International|November 15, 2011
The risk of a second hip fracture in patients after their first hip fractureHiroshi Hagino, Takeshi Sawaguchi, Naoto Endo, et al.
Journal of Bone and Mineral Metabolism|October 15, 2015
Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER studyTetsuo Nakano, Masao Yamamoto, Junko Hashimoto, et al.
Asia Pacific Journal of Clinical Nutrition|March 12, 2011
High prevalence of hypovitaminosis D and K in patients with hip fractureTetsuo Nakano, Naoko Tsugawa, Akiko Kuwabara, et al.
Bioscience, Biotechnology, and Biochemistry|June 25, 2004
Identification and cloning of the gene involved in the final step of chlortetracycline biosynthesis in Streptomyces aureofaciensTetsuo Nakano, Koichiro Miyake, Hirofumi Endo, et al.
Brain Research|February 24, 2009
Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized miceFeng Han, Tetsuo Nakano, Yui Yamamoto, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|May 20, 2011
Serum 25-hydroxyvitamin D status in hip and spine-fracture patients in JapanMayumi Sakuma, Naoto Endo, Hiroshi Hagino, et al.
Calcified Tissue International|May 7, 2013
Clinical efficacy on fracture risk and safety of 0.5 mg or 1 mg/month intravenous ibandronate versus 2.5 mg/day oral risedronate in patients with primary osteoporosisToshitaka Nakamura, Tetsuo Nakano, Masako Ito, et al.
Pageof 5